Electrocardiographic Abnormalities and Sudden Death in Myotonic Dystrophy Type 1
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Sudden death can occur as a consequence of cardiac-conduction abnormalities in the neuromuscular disease myotonic dystrophy type 1. The determinants of the risk of sudden death remain imprecise. METHODS: We assessed whether the electrocardiogram (ECG) was useful in predicting sudden death in 406 adult patients with genetically confirmed myotonic dystrophy type 1. A patient was characterized as having a severe abnormality if the ECG had at least one of the following features: rhythm other than sinus, PR interval of 240 msec or more, QRS duration of 120 msec or more, or second-degree or third-degree atrioventricular block. RESULTS: Patients with severe abnormalities according to the entry ECG were older than patients without severe abnormalities, had more severe skeletal-muscle impairment, and were more likely to have heart failure, left ventricular systolic dysfunction, or atrial tachyarrhythmia. Such patients were more likely to receive a pacemaker or an implantable cardioverter-defibrillator during the follow-up period. During a mean follow-up period of 5.7 years, 81 patients died; there were 27 sudden deaths, 32 deaths from progressive neuromuscular respiratory failure, 5 nonsudden deaths from cardiac causes, and 17 deaths from other causes. Among the 17 patients who died suddenly in whom postcollapse rhythm was evaluated, a ventricular tachyarrhythmia was observed in 9. A severe ECG abnormality (relative risk, 3.30; 95% confidence interval [CI], 1.24 to 8.78) and a clinical diagnosis of atrial tachyarrhythmia (relative risk, 5.18; 95% CI, 2.28 to 11.77) were independent risk factors for sudden death. CONCLUSIONS: Patients with adult myotonic dystrophy type 1 are at high risk for arrhythmias and sudden death. A severe abnormality on the ECG and a diagnosis of an atrial tachyarrhythmia predict sudden death. (ClinicalTrials.gov number, NCT00622453.)
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
The Cardiac Arrhythmia Suppression Trial (CAST) Investigators (1989) · New England Journal of Medicine · doi:10.1056/nejm198908103210629 · Cited by 3,300
Brook, J. D., McCurrach, M. E., Harley, H. G., Buckler, A. J., Church, D., Aburatani, H., Hunter, K., Stanton, V. P., Thirion, J.-P., Hudson, T., et al. (1992) · Cell · doi:10.1016/0092-8674(92)90154-5 · Cited by 2,777
Benjamin, E. J. (1994) · JAMA · doi:10.1001/jama.1994.03510350050036 · Cited by 2,613
An Unstable Triplet Repeat in a Gene Related to Myotonic Muscular Dystrophy
Fu, Y. H., Pizzuti, A., Fenwick, R. G., King, J., Rajnarayan, S., Dunne, P. W., Dubel, J., Nasser, G. A., Ashizawa, T., de Jong, P., et al. (1992) · Science · doi:10.1126/science.1546326 · Cited by 1,455
Gregoratos, G., Abrams, J., Epstein, A. E., Freedman, R. A., Hayes, D. L., Hlatky, M. A., Kerber, R. E., Naccarelli, G. V., Schoenfeld, M. H., Silka, M. J., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02528-7 · Cited by 1,266
Committee Members, Gregoratos, G., Abrams, J., Epstein, A. E., Freedman, R. A., Hayes, D. L., Hlatky, M. A., Kerber, R. E., Naccarelli, G. V., Schoenfeld, M. H., et al. (2002) · Circulation · doi:10.1161/01.cir.0000035996.46455.09 · Cited by 910
Chugh, S. S., Jui, J., Gunson, K., Stecker, E. C., John, B. T., Thompson, B., Ilias, N., Vickers, C., Dogra, V., Daya, M., et al. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.06.029 · Cited by 795
Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy
Buxton, J., Shelbourne, P., Davies, J., Jones, C., Tongeren, T. V., Aslanidis, C., de Jong, P., Jansen, G., Anvret, M., Riley, B., et al. (1992) · Nature · doi:10.1038/355547a0 · Cited by 620
Cloning of the essential myotonic dystrophy region and mapping of the putative defect
Aslanidis, C., Jansen, G., Amemiya, C., Shutler, G., Mahadevan, M., Tsilfidis, C., Chen, C., Alleman, J., Wormskamp, N. G. M., Vooijs, M., et al. (1992) · Nature · doi:10.1038/355548a0 · Cited by 498
A 10-year study of mortality in a cohort of patients with myotonic dystrophy
Mathieu, J., Allard, P., Potvin, L., Prévost, C., & Bégin, P. (1999) · Neurology · doi:10.1212/wnl.52.8.1658 · Cited by 414
Research works printed but not linked: 2
- Florek RC, 1990, West J Med, 153, 24
- 10.1001/jama.271.11.840 · DOI · Paper page
Cited by
Items 301–400 of 511
Neuromuscular diseases: new hopes for alleviation and elimination
Ludolph, A. C. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70277-1 · Cited by 5
Progressive conduction disturbance in myotonic dystrophy.
Palazzolo, J., Trucco, E., Arce, M., Pérez‐Riera, A. R., & Femenía, F. (2011) · PubMed · Cited by 5
SERUM cardiac‐specific biomarkers and atrial fibrillation in myotonic dystrophy type I
Russo, V., Rago, A., Atripaldi, L. G., Leonardi, S., Papa, A. A., Politano, L., Golino, P., Potpara, T., & Nigro, G. (2019) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.14211 · Cited by 5
“Atrial fibrillation (AF) frequently occurs in DM1 patients, and the occurrence of AF has been associated with increased mortality in this population.(2,3) Considering the unfavorable prognostic implications of AF, early identification of DM1 patients at increased risk of paroxysmal AF is of key importance for the opti…”
BackgroundWang, J., Liu, M., Shang, W., Chen, Z., & Peng, G. (2020) · BMC Neurology · doi:10.1186/s12883-020-01636-0 · Cited by 5
Cardiac magnetic resonance findings and prognosis in type 1 myotonic dystrophy
Leali, M., Aimo, A., Ricci, G., Torri, F., Todiere, G., Vergaro, G., Grigoratos, C., Giannoni, A., Aquaro, G. D., Siciliano, G., et al. (2023) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000001476 · Cited by 5
Update on Therapy for Myotonic Dystrophy Type 1
Ivanović, V., Meola, G., Vukojević, Z., & Perić, S. (2023) · Current Treatment Options in Neurology · doi:10.1007/s11940-023-00760-9 · Cited by 7
DM1 Patients with Small CTG Expansions are also at Risk of Severe Conduction Abnormalities
Denicourt, M., Pham, M. T., Mathieu, J., & Breton, R. (2015) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-140025 · Cited by 5
“These have been associated with an increased risk of mortality from sudden cardiac death [12, 19, 20].”
InfluentialNeurologic Disorders and Cardiovascular Disease
Groh, W. J., & Zipes, D. P. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0398-6.00092-5 · Cited by 5
Self-citationOtsubo, T., Tsuchiya, T., Yamaguchi, T., & Takahashi, N. (2018) · Journal of Arrhythmia · doi:10.1002/joa3.12059 · Cited by 5
“AF is sometimes found with an occurrence rate of 25%, which is an independent predictor of sudden cardiac death in MD.(2) Low-voltage zones (LVZs) are known to be a substrate of atrial fibrillation (AF), and an LVZ ablation after a pulmonary vein antrum isolation (PVAI) has been shown to improve the outcomes in patien…”
BackgroundXiong, N., Liu, W., Li, J., Luo, S., Gu, W., Zhu, W., Xi, J., Lin, J., Wu, B., & Luo, X. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e13940 · Cited by 4
Li, L., Xie, S., & Deng, W. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.177101 · Cited by 3
Sigmoid Volvulus in Myotonic Dystrophy Type I (Steinert Disease)
Bayoumy, A. B., Gjertsen, J. S., & Tushuizen, M. E. (2022) · Case Reports in Gastroenterology · doi:10.1159/000522476 · Cited by 4
Myotonic dystrophy: genetics and clinical polymorphism
Иванова, Е. О., Moskalenko, A. N., Fedotova, E. Y., Kurbatov, S. A., & Illarioshkin, S. N. (2019) · Annals of Clinical and Experimental Neurology · doi:10.25692/acen.2019.1.2 · Cited by 4
Atrial Flutter in Particular Patient Populations
Compagnucci, P., Casella, M., Bagliani, G., Capestro, A., Volpato, G., Valeri, Y., Cipolletta, L., Parisi, Q., Molini, S., Misiani, A., et al. (2022) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2022.05.002 · Cited by 4
Ventricular tachycardia: fi rst manifestation of myotonic dystrophy
Çakmak, N., Osmonov, D., Özcan, K. S., & Dönmez, C. (2011) · Acta cardiologica. Supplementum · doi:10.1080/ac.66.2.2071264 · Cited by 4
Forensic Considerations in Cases of Myotonic Dystrophy at Autopsy
Omond, K. J., & Byard, R. W. (2017) · Journal of Forensic Sciences · doi:10.1111/1556-4029.13444 · Cited by 4
“cognitive and intellectual deficits, and gastrointestinal problems, including dysphagia and delayed gastric emptying (1,7,8).”
BackgroundChinnery, P. F. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1604-7.00429-2 · Cited by 4
Russo, V., Rago, A., Papa, A. A., & Nigro, G. (2017) · Journal of the Chinese Medical Association · doi:10.1016/j.jcma.2017.07.006 · Cited by 4
“9% in 180 DM1 patients who underwent echocardiographic evaluation; Petri et al.(3) reported a LVD prevalence of 20.”
InfluentialDrosophila melanogaster: A Model Organism in Muscular Dystrophy Studies
Zhao, Y., Wang, Y., Tulehalede, A., Meng, Z., Xu, L., Bai, H., Sha, J., Xie, W., & Geng, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26041459 · Cited by 3
Symptomatic Trifascicular Block in Steinert’s Disease: Is It Too Soon for a Pacemaker?
Lasam, G. U., Roberti, R., LaCapra, G., & Ramírez, R. (2016) · Case Reports in Cardiology · doi:10.1155/2016/6372181 · Cited by 3
Saito, T., Kuru, S., Takahashi, T., Suzuki, M., & Ogata, K. (2019) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.cn-001229 · Cited by 3
Predictors of respiratory failure and survival in myotonic dystrophy type 1
Mélone, M.-A., Dabaj, I., Patout, M., Gillibert, A., Artaud-Macari, É., Guyant‐Maréchal, L., Bédat‐Millet, A., Guerrot, A., Salaün, M., Bekri, S., et al. (2025) · Journal of Neuromuscular Diseases · doi:10.1177/22143602251386258 · Cited by 3
Cardiac Implantable Electronic Device Therapy for Bradyarrhythmias and Tachyarrhythmias
Corcoran, S. J., & Davis, L. M. (2012) · Heart Lung and Circulation · doi:10.1016/j.hlc.2012.03.009 · Cited by 4
Czosek, R. J., Goldenberg, P. C., Miller, E. M., Spicer, R. L., Towbin, J. A., & Ware, S. M. (2012) · Cardiogenetics · doi:10.4081/cardiogenetics.2012.e2 · Cited by 3
The current status of medical care for myotonic dystrophy type 1 in the national registry of Japan
Yamauchi, K., Matsumura, T., Takada, H., Kuru, S., Kobayashi, M., Kubota, T., Kimura, E., Nakamura, H., & Takahashi, M. P. (2023) · Muscle & Nerve · doi:10.1002/mus.27799 · Cited by 5
“For cardiac-related diseases, a PR interval of over 240 milliseconds and QRS duration over 120 milliseconds have been reported as risk factors for sudden death.(25,26) These were present in approximately 30% of registrants in our study, excluding those with PM or ICD implantation, which is consistent with reports from…”
ResultCombinatorial effects of ion channel mis-splicing as a cause of myopathy in myotonic dystrophy
Nitschke, L., & Cooper, T. A. (2024) · Journal of Clinical Investigation · doi:10.1172/jci176089 · Cited by 3
“DM1 features include cardiac condition abnormalities experienced by more than 50% of those affected, with at least 20% mortality due to fatal arrhythmias (17, 18).”
BackgroundAdvanced Heart Failure Therapies in Neuromuscular Diseases
Agdamag, A. C., Nandar, P. P., & Tang, W. H. W. (2024) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-024-01046-2 · Cited by 5
“Despite guideline directed therapy for heart failure, most patients can progress to end-stage heart failure requiring advanced therapies with either left ventricular assist devices or cardiac transplantation [35, 60, 61].”
Neurological complications of cardiomyopathies
Fonseca, A. C., Almeida, A. G., Santos, M. O., & Ferro, J. M. (2021) · Handbook of clinical neurology · doi:10.1016/b978-0-12-819814-8.00001-9 · Cited by 3
Les anomalies cardiaques au cours de la dystrophie myotonique de Steinert
Miladi, M. I., Charfeddine, H., Feki, I., Turki, E., Elleuch, N., Trabelsi, I., Krichène, S., Kammoun, S., & Mhiri, C. (2009) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2009.01.017 · Cited by 3
Myotone Dystrophien – und ihre Differenzialdiagnosen
Schoser, B. G. H., & Grimm, T. (2009) · Medizinische Genetik · doi:10.1007/s11825-009-0178-3 · Cited by 3
The Genetics of Conduction Disease
Beinart, R., Ruskin, J. N., & Milan, D. J. (2010) · Heart Failure Clinics · doi:10.1016/j.hfc.2009.11.006 · Cited by 3
Myotonic dystrophy and out-of-hospital arrest
Kamara, A., Nijjer, S. S., Ghosh, A. K., Grocott-Mason, R. M., & Dubrey, S. W. (2010) · Clinical Medicine · doi:10.7861/clinmedicine.10-6-630 · Cited by 3
Sansone, V., Ambroggi, G. D., Zanolini, A., Panzeri, M., Sardanelli, F., Cappato, R., Meola, G., & AMBROGGI, L. D. (2009) · EP Europace · doi:10.1093/europace/eup155 · Cited by 3
“–4 The incidence of sudden cardiac death is increased compared with the general population.(1) The identification of patients at risk for sudden cardiac death is still challenging, even though larger cytosine-thymine-guanine trinucleotide repeat expansions and ECG abnormalities (rhythm other than sinus, PR interval 24…”
BackgroundWheeler, T. M., Baker, J. N., Chad, D. A., Zilinski, J. L., Verzosa, S., & Mordes, D. A. (2015) · New England Journal of Medicine · doi:10.1056/nejmcpc1415169 · Cited by 3
Abnormal Muscle Pathology and Physiology
Bogdanovich, S., Gardner, B. B., & McNally, E. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800040-3.00004-2 · Cited by 3
Cardiac Complications of Neuromuscular Disorders
Spurney, C. F. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4377-0372-6.00003-7 · Cited by 3
Yoshino, K., Takahashi, K., Eda, Y., Nishigaki, A., & Kitao, M. (1991) · PubMed · Cited by 4
Okşul, M., Bilge, Ö., Türken, A., Işık, F., Akyüz, A., Çap, M., Söner, S., Akın, H., Şener, Y. Z., & Taştan, E. (2023) · Cureus · doi:10.7759/cureus.34600 · Cited by 3
“Patients who have cardiac involvement secondary to MD1 may experience palpitations, dizziness, fatigue, or sometimes syncope, but are often asymptomatic [1,2,5,6].”
What the internist should know about hereditary muscle channelopathies
Bissay, V., & Malderen, S. C. H. V. (2017) · Acta Clinica Belgica · doi:10.1080/17843286.2017.1396674 · Cited by 3
Cardiomyopathies and Arrythmias in Neuromuscular Diseases
Sgarito, G. A., Volpe, C., Bardari, S., Calvanese, R., China, P., Mascioli, G., Nesti, M., Pignalberi, C., Cipriani, M., & Zecchin, M. (2025) · Cardiogenetics · doi:10.3390/cardiogenetics15010007 · Cited by 2
“Groh et al. [54] highlighted that prolonged PR intervals (>240 ms), QRS durations > 120 ms, second-or third-degree AVB, and atrial tachyarrhythmias are independent predictors of SD via multivariate analysis.”
Evaluation of echocardiography monitoring in myotonic dystrophy type 1 patients
Bovenkerk, D., Janssen, C. E. W., van den Heuvel, F. M. A., Joosten, I. B. T., den Uijl, D. W., van Engelen, B. G. M., van Kuijk, S. M. J., Nijveldt, R., Evertz, R., Faber, C. G., et al. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1574885 · Cited by 2
“Early detection of arrhythmias and conduction disturbances is important to prevent life threatening complications (5).”
Johnson, N. E., Bhandaru, V., Andrews, J., Jaff, T. A., Venkatesh, Y. S., Raucci, F. J., Soim, A. S., Ciafaloni, E., & Rice, M. M. (2025) · Neurology Genetics · doi:10.1212/nxg.0000000000200322 · Cited by 2
Self-citationAlberti, C., Parente, V., Corti, S. P., & Sansone, V. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107192 · Cited by 3
Shimoyama, T., Hayashi, H., Suzuki, F., Nishiyama, Y., Miyamoto, Y., Aiba, T., Shimizu, W., & Kimura, K. (2020) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2020.02.007 · Cited by 2
Táborský, M., Kautzner, J., Fedorco, M., Čurila, K., Wünschová, H., Pyszko, J., Novák, M., Kozák, M., Válek, M., Polášek, R., et al. (2022) · Cor et Vasa · doi:10.33678/cor.2022.024 · Cited by 4
Cerbin, L. P., Sandhu, A., Rosenberg, M., Barrett, C., Sabzwari, R., Garg, L., Tumolo, A. Z., Tzou, W. S., Varosy, P. D., von Alvensleben, J. C., et al. (2024) · Heart Rhythm O2 · doi:10.1016/j.hroo.2024.08.001 · Cited by 2
Childs, A., Henderson, R. D., Henderson, D., Waldmann, J., & Szollosi, I. (2025) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2025.123470 · Cited by 2
A case of unusual hand pain in general practice
Mughal, F., Rashid, A., & Mishra, R. C. (2015) · BMJ · doi:10.1136/bmj.h5005 · Cited by 2
Quand implanter un stimulateur cardiaque dans la maladie de Steinert ?
Babuty, D., Lallemand, B., Laurent, V., Clémenty, N., Pierre, B., Fauchier, L., Raynaud, M., & Pellieux, S. (2011) · La Presse Médicale · doi:10.1016/j.lpm.2011.01.029 · Cited by 2
Muscular Dystrophies and Neurologic Diseases that Present as Myopathy
Quan, D. (2011) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2011.01.006 · Cited by 2
Simmons, Z. (2009) · Journal of Clinical Neuromuscular Disease · doi:10.1097/cnd.0b013e3181a7b35f · Cited by 3
Self-citationA case of myotonic dystrophy presenting with ventricular tachycardia and atrial fibrillation.
Eroğlu, S., Özin, B., Özbiçer, S., & Müderrisoğlu, H. (2009) · PubMed · Cited by 2
Arrhythmias in Patients With Neurologic Disorders
Groh, W. J. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-2856-5.00100-x · Cited by 2
Self-citationCauses of sudden death in the young — Cardiac and non-cardiac
Lang, J., Pflaumer, A., & Davis, A. M. (2017) · Progress in Pediatric Cardiology · doi:10.1016/j.ppedcard.2017.02.007 · Cited by 2
Molecular Mechanisms of Myotonic Dystrophy: RNA-Mediated Pathogenesis and RNA-Binding Proteins
Kino, Y., Satoh, J., & Ishiura, S. (2018) · Springer eBooks · doi:10.1007/978-981-13-0508-5_2 · Cited by 2
A rare case report of severe cardiomyopathy associated with myotonic dystrophy type 2
Touma, A. M., Nijjar, P. S., Manousakis, G., & Kamdar, F. D. (2022) · European Heart Journal - Case Reports · doi:10.1093/ehjcr/ytac015 · Cited by 2
“recognized cardiac manifestations, and the primary cause of death is cardiac in 20–29% of patients.(5,6) In DM2, cardiovascular involvement”
BackgroundAz ischaemiás stroke kockázati tényezői a dystrophia myotonica 1-es típusában
Varga, D., Ruszin-Perecz, B., Sipos, A., Jedlicska, D., & Pál, E. (2022) · Orvosi Hetilap · doi:10.1556/650.2022.32620 · Cited by 2
Termsarasab, P., Baajour, W., Thammongkolchai, T., & Katirji, B. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6567-6_59 · Cited by 2
Description of muscle disease – specific diseases
Karpati, G. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511674747.014 · Cited by 2
Sugie, M., & Sugie, K. (2016) · Journal of Rare Disorders: Diagnosis & Therapy · doi:10.21767/2380-7245.100048 · Cited by 2
“Because many patients with DM1 have arrhythmias and cardiac dysfunction, cardiac involvement is the most important life-threatening, prognostic factor in DM1 and accounts for approximately one third of the deaths in this population [13-15].”
BackgroundDystrophia myotonica type 1 presenting with dysarthria: A case report and literature review
Li, C., Zhang, X., Zhou, C., Zhu, L., Liu, K., & Fang, S. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4579 · Cited by 2
“The involvement of multiple organ systems may also complicate the pathophysiology of DM type 1 (23).”
Kupó, P., Fődi, E., Debreceni, D., Pál, E., Faludi, R., Tényi, D., Molnár, F., Lovadi, E., Varga, D., & Símor, T. (2021) · Orvosi Hetilap · doi:10.1556/650.2021.32279 · Cited by 2
Disability and Physical Exercise in adults with Myotonic Dystrophy type 1
Kierkegaard, M. (2010) · Figshare · Cited by 2
Should we perform systematic electrophysiological study in Steinert's disease?
Fayssoil, A. (2008) · Journal of Cardiothoracic Surgery · doi:10.1186/1749-8090-3-56 · Cited by 2
“[6], MD1 patients with severe abnormality (ECG with at least one of the following features: rhythm other than sinus, PR interval of 240 msec or more, QRS duration of 120 msec or more, or second-degree or thirddegree AV block) were at risk for sudden death [6].”
BackgroundThe Role of Implantable Cardiac Electrical Devices in Patients with Myotonic Dystrophy
Curtis, A. B., & Dalal, K. (2011) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2011.02221.x · Cited by 2
Ekström, A. (2009) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 3
Repeats and Survival in Myotonic Dystrophy Type 1
Wheeler, M. T. (2017) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.117.001783 · Cited by 2
Electrophysiologic Consequences and Sudden Death in Myotonic Dystrophy
Etheridge, S. P., & Niu, M. C. (2021) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2021.07.002 · Cited by 2
Johnson, N. E., & Heatwole, C. R. (2011) · Neuromuscular Disorders · doi:10.1002/9781119973331.ch10 · Cited by 2
de Die-Smulders, C. E. M., Jennekens, F. G. I., & Faber, C. G. (2010) · Wiley eBooks · doi:10.1002/9780470893159.ch36 · Cited by 2
Multimodales Monitoring und Therapie der Myotonen Dystrophien
Schüller, A., Wenninger, S., Montagnese, F., & Schoser, B. G. H. (2016) · DNP - Der Neurologe und Psychiater · doi:10.1007/s15202-016-1039-y · Cited by 1
“Eine kardiale Beteiligung zeigt sich insbesondere als Tachyarrhythmien und Reizleitungsstörungen mit der Gefahr eines plötzlichen Herztodes [9].”
BackgroundMoxley, R. T., Hilbert, J. E., & Meola, G. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813866-3.00029-1 · Cited by 1
Silvestri, G., & Modoni, A. (2023) · Current clinical neurology · doi:10.1007/978-3-031-44009-0_3 · Cited by 1
Extended Cardiac Rhythm Monitoring Detects More Arrhythmias in Myotonic Dystrophy Patients
Russo, V. (2025) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2025.03.041 · Cited by 1
Perez, P. G. (2025) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/cont.0000000000001621 · Cited by 1
Jajkiewicz, C., Pouliot, V., & Chahine, M. (2026) · Heart Rhythm · doi:10.1016/j.hrthm.2026.02.013 · Cited by 2
Developing endpoints for the cardiac burden in myotonic dystrophy type 1: A workshop report
Hartman, J., Carrell, S., Groh, W. J., Cooper, T. A., Kron, J., Hundley, G. W., Jordan, J. H., Ladd, A., Hung, M., & Johnson, N. E. (2026) · Journal of Neuromuscular Diseases · doi:10.1177/22143602261433484 · Cited by 1
“Using averaged rates of progression (PR: ∼ 2.98 ms/year; QRS: ∼ 1.63 ms/year), 5,21,22 we estimated the minimum detectable difference in annualized progression for studies with varying sample sizes and follow-up durations.”
InfluentialSelf-citationLans, M., Grundell, L., Parén, P., Ljungman, C. E. A., Klintberg, L., & Mourtzinis, G. (2026) · International Journal of Cardiology · doi:10.1016/j.ijcard.2026.134679 · Cited by 1
Neuromuscular Respiratory Failure
Boesch, R. P., & Sawnani, H. (2014) · Springer eBooks · doi:10.1007/978-1-4471-6356-5_16 · Cited by 1
Cardiomyopathy secondary to Steinert's dystrophy
Jorge, B. A. L., do Carmo, F. B., Haffner, P., Jorge, A. J. L., & Martins, W. D. A. (2012) · Insuficiencia cardiaca: revista especializada en insuficiencia cardíaca, cardiometabolismo e hipertensión pulmonar · Cited by 1
Rinaldi, F., Botta, A., Vallo, L., Contino, G., Morgante, A., Iraci, R., Catalli, C., Silvestri, G., Ventriglia, V. M., Politano, L., et al. (2008) · PubMed Central · Cited by 1
Sudden cardiac death diagnosed with dilated cardiomyopathy in a Kuwaiti family: a case report
Bulbanat, B., Antony, D., Behbehani, K., Alsmadi, O. A., Thomas, D., & Kamkar, M. M. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-914 · Cited by 1
Patoine, D., Hasibu, I., Pilote, S., Champagne, J., Drolet, B., & Simard, C. (2011) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2010.12.045 · Cited by 1
Taquicardia ventricular sincopal como primera manifestación de la enfermedad de Steinert
Anguera, I., Nicolás, J., Sabaté, X., & Esplugas, E. (2010) · Revista Española de Cardiología · doi:10.1016/s0300-8932(10)70018-x · Cited by 1
Syncopal Ventricular Tachycardia as the First Manifestation of Steinert's Disease
Anguera, I., Nicolás, J., Sabaté, X., & Esplugas, E. (2010) · Revista Española de Cardiología (English Edition) · doi:10.1016/s1885-5857(10)70018-9 · Cited by 1
Non-Ischemic Cardiomyopathy Attributed to Adult Myotonic Dystrophy
Park, H., Park, W. H., Song, D., Kim, T. G., Min, B. Y., Lee, K., & Park, J.-I. (2009) · Korean Circulation Journal · doi:10.4070/kcj.2009.39.8.340 · Cited by 1
Day, J., & Thornton, C. A. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511674747.022 · Cited by 1
Hereditary Cardiac Conduction Diseases
Tadros, R., & Cadrin‐Tourigny, J. (2016) · Springer eBooks · doi:10.1007/978-3-319-44203-7_16 · Cited by 1
Cardiac Complications of Neuromuscular Disorders
Spurney, C. F., & Schramm, J. E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-71317-7.00003-2 · Cited by 1
Hereditary Neuromuscular Diseases and Cardiac Involvement
van der Kooi, A. J., Wahbi, K., Bonne, G., & de Visser, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-44203-7_23 · Cited by 1
Systemic Diseases and Heart Block
Sabzwari, S. R. A., & Tzou, W. S. (2023) · Cardiology Clinics · doi:10.1016/j.ccl.2023.03.008 · Cited by 2
Systemic Complications of Muscular Dystrophies
Kassardjian, C. D., & Liewluck, T. (2023) · Current clinical neurology · doi:10.1007/978-3-031-44009-0_17 · Cited by 1
Meziab, O. Z., Seckeler, M. D., Scherer, K. H., & Barber, B. J. (2024) · Muscle & Nerve · doi:10.1002/mus.28188 · Cited by 1
Moxley, R. T., Hilbert, J. E., & Meola, G. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19176-3.00029-7 · Cited by 1
Thornton, C. A. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-381510-1.00068-5 · Cited by 1
Ion channel messenger RNA processing defects and arrhythmia
Dudley, S. C., & Zhou, A. (2014) · Current Biomarker Findings · doi:10.2147/cbf.s37417 · Cited by 1
“Up to one third of DM1 patients die suddenly, most often because of asystole after atrioventricular block or from ventricular fibrillation.(51) Increased neonatal exon 6 splicing variant of SCN5A, called exon 6A, has been detected in ventricular myocardial specimens from BrS patients with DM1.”
BackgroundMuscular dystrophies and the heart: The emerging role of cardiovascular magnetic resonance imaging
Mavrogeni, S. I., & Markousis‐Mavrogenis, G. (2015) · Current research. Cardiology · doi:10.4172/2368-0512.1000030 · Cited by 1
Intensive Care Management, Including Cardiorespiratory Care
Scott, W. A., & Iannaccone, S. T. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-417044-5.00044-5 · Cited by 1
Tanawuttiwat, T., Tomaselli, G. F., & Nazarian, S. (2017) · JAMA Cardiology · doi:10.1001/jamacardio.2017.0859 · Cited by 1
Cardiac Involvements in Myotonic Dystrophy
Itoh, H., & Tamura, T. (2018) · Springer eBooks · doi:10.1007/978-981-13-0508-5_4 · Cited by 1
Metadata
- Authors
- Groh, W. J., Groh, M. R., Saha, C., Kincaid, J. C., Simmons, Z., Ciafaloni, E., Pourmand, R., Otten, R. F., Bhakta, D., Nair, G. V., Marashdeh, M. M., Zipes, D. P., & Pascuzzi, R. M.
- Affiliations
- Indiana University Indianapolis (US)
- Pennsylvania State University (US)
- University of Rochester Medicine (US)
- State University of New York (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2008-06-19
- Volume
- 358
- Issue
- 25
- Pages
- 2688-2697
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2083028245
- Cited by
- 511
- References
- 32
- Citations by year
- 2026: 19 · 2025: 21 · 2024: 19 · 2023: 22 · 2022: 26 · 2021: 30 · 2020: 34 · 2019: 31 · 2018: 36 · 2017: 39 · 2016: 34 · 2015: 28 · 2014: 32 · 2013: 20 · 2012: 32
- FWCI
- 20.88
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Center for Research Resources (MO1 RR00750-27S1, M01RR000750)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Keywords
- myotonic dystrophy type 1, sudden death, electrocardiographic abnormalities, atrial tachyarrhythmia, ventricular tachyarrhythmia, cardiac conduction disorders, atrioventricular block, risk factors, implantable cardioverter-defibrillator, cardiac pacemaker, neuromuscular disorders
- MeSH terms
- Adult, Arrhythmias, Cardiac, Cause of Death, Electrocardiography, Female, Follow-Up Studies, Humans, Male, Middle Aged, Myotonic Dystrophy, Prognosis, Risk Factors, Tachycardia, Death, Sudden, Cardiac
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.